北京大学学报(医学版) ›› 2017, Vol. 49 ›› Issue (6): 937-947. doi: 10.3969/j.issn.1671-167X.2017.06.002

• 论著 • 上一篇    下一篇

沉默液泡型ATP酶c亚基ATP6V0C抑制人前列腺癌细胞侵袭的分子机制

邹鹏程1,2,杨一峰1,徐晓艳1,3,4,刘北英5,梅放1,由江峰1,刘启忱6,裴斐1△   

  1. (1. 北京大学基础医学院病理学系, 北京100191; 2. 青岛中心医院病理科, 山东青岛266000; 3. 内蒙古医学院基础医学院病理学系, 呼和浩特010059; 4.内蒙古医学院附属医院病理科, 呼和浩特010059; 5.北京科技大学机械学院, 北京100083;6.首都师范大学附属育新学校, 北京100096)
  • 出版日期:2017-12-18 发布日期:2017-12-18
  • 通讯作者: 裴斐 E-mail: peifei@bjmu.edu.cn
  • 基金资助:
    国家自然科学基金(81572533)资助

Silencing of vacuolar ATPase c subunit ATP6V0C inhibits invasion of prostate cancer cells

ZOU Peng-cheng1,2, YANG Yi-feng1, XU Xiao-yan1,3,4, LIU Bei-ying5, MEI Fang1, YOU Jiang-feng1, LIU Qi-chen6, PEI Fei 1△   

  1. (1. Department of Pathology, Peking University School of Basic Medical Sciences, Beijing 100191, China; 2. Department of Pathology, Qingdao Central Hospital, Qingdao 266000, Shandong, China; 3. Department of Pathology, School of Basic Medical Sciences, Inner Monglia Medical College, Huhhot 010059, China; 4. Department of Pathology, The Affiliated Hospital of Inner Monglia Medical College, Huhhot 010059, China; 5. School of Mechanical Engineering, University of Science & Technology Beijing, Beijing 100083, China; 6. Yuxin School attached to Capital Normal University,Beijing 100096, China)
  • Online:2017-12-18 Published:2017-12-18
  • Contact: PEI Fei E-mail: peifei@bjmu.edu.cn
  • Supported by:
    Supported by the National Natural Science Foundation of China(81572533)

摘要: 目的: 采用RNA干涉技术沉默液泡型ATP酶c亚基ATP6V0C的表达,探索ATP6V0C在前列腺癌侵袭中的分子作用机制,并研究其与LASS2/TMSG1的关系。方法与结果: ATP6V0C在高转移潜能人前列腺癌细胞系(PC-3M-1E8和PC-3M)中的表达明显高于低转移潜能人前列腺癌细胞系(PC-3M-2B4和PC-3), 选择ATP6V0C表达量最高的PC-3M-1E8细胞进行基因沉默实验,发现ATP6V0C的siRNA转染PC-3M-1E8后,其基质金属蛋白酶2(matrix metalloprotein-2,MMP-2)和基质金属蛋白酶9(MMP-9)蛋白的表达量及MMP-2的分泌量均无明显变化,但上清液中MMP-9的活性明显减弱,与空白对照组及阴性对照组相比,差异有统计学意义(P<0.05);干扰组细胞外氢离子浓度及液泡型ATPase的活性明显降低(P<0.05);细胞划痕修复实验及transwell体外侵袭实验结果显示ATP6V0C siRNA干扰组细胞的体外迁移及侵袭能力明显减弱(P<0.05)。PC-3M-1E8细胞转染ATP6V0C siRNA后,LASS2/TMSG1的表达明显减弱(P<0.05)。免疫荧光双重染色结果显示ATP6V0C蛋白与LASS2/TMSG1共定位于胞浆和胞膜,干扰组共定位信号与对照组相比明显减弱。结论: 特异性siRNA沉默ATP6V0C能抑制人前列腺癌细胞的迁移和侵袭能力,其机制与ATP6V0C沉默后抑制V-ATPase的活性,使细胞外氢离子浓度降低,抑制MMP-9的激活,从而影响细胞外基质的降解和重塑有关。靶向siRNA干扰ATP6V0C的表达后,可能通过反馈调节机制抑制LASS2/TMSG1的表达,但其具体分子机制尚待进一步研究。

关键词: 液泡型ATP酶, ATP6V0C, LASS2/TMSG1, 前列腺癌, 基因沉默

Abstract: Objective: Vacuolar ATPase (V-ATPase) was found within the membranes and internal organelles of a vast array of eukaryotic cells, and was related to various kinds of highly metastatic tumors. LASS2/TMSG1 gene was a novel tumor metastasis suppressor gene cloned from human prostate cancer cell line PC--3M in 1999 by our laboratory. It was found out that protein encoded by LASS2/TMSG1 could interact with the c subunit of V-ATPase (ATP6V0C). In this study, To use RNA interference to suppress the expression of ATP6V0C and try to further investigate the molecular mechanism of ATP6V0C in tumor metastasis and its relationship with LASS2/TMSG1 gene. Methods and Results: The expression level of ATP6V0C mRNA and protein in high metastatic potential prostate cancer cell lines (PC-3M-1E8 and PC-3M) was significantly higher than that in low metastatic potential prostate cancer cell lines (PC-3M-2B4 and PC-3), the expression level in PC-3M-1E8 being the highest. Follow-up tests selected PC-3M-1E8 cells for gene silencing. The expression and secretion of MMP-2 and the expression of MMP-9 in ATP6V0C siRNA transfected PC-3M-1E8 cells displayed no obvious change, but the activity of secreted MMP-9 was abated noticeably compared with the controls (P<0.05). Extracellular hydrogen ion concentration and V-ATPase activity in interference group were both reduced significantly compared with the controls (P<0.05). The migration and invasion capacity of ATP6V0C siRNA interfered cells in vitro were diminished significantly compared with the controls (P<0.05). Furthermore, a dramatic reduction of LASS2/TMSG1 mRNA and protein level after transfection of siRNA in PC-3M-1E8 cells was discovered (P<0.05). Confocal immunofluorescence showed a vast co-localization of ATP6V0C protein and LASS2/TMSG1 protein in plasma and membrane. The co-localization signals of control group were much stronger than those of interference group. Conclusion: Specific siRNA silencing of ATP6V0C gene inhi-bits the invasion of human prostate cancer cells in vitro by mechanism of inhibiting V-ATPase activity and then reducing the extracellular hydrogen ion concentration, inhibiting MMP-9 activation and affecting ECM degradation and reconstruction. Meanwhile, ATP6V0C and LASS2/TMSG1 have interaction and it is likely that ATP6V0C functions as a feedback regulator of LASS2/TMSG1.

Key words: Vacuolar ATPase, ATP6V0C, LASS2/TMSG1, Prostate cancer, Gene silence

中图分类号: 

  • R737.25
[1] 邢念增,王明帅,杨飞亚,尹路,韩苏军. 前列腺免活检创新理念的临床实践及其应用前景[J]. 北京大学学报(医学版), 2024, 56(4): 565-566.
[2] 黄教悌,胡菁,韩博. 治疗相关神经内分泌前列腺癌机制研究与靶向治疗新进展[J]. 北京大学学报(医学版), 2024, 56(4): 557-561.
[3] 颜野,李小龙,夏海缀,朱学华,张羽婷,张帆,刘可,刘承,马潞林. 前列腺癌根治术后远期膀胱过度活动症的危险因素[J]. 北京大学学报(医学版), 2024, 56(4): 589-593.
[4] 于书慧,韩佳凝,钟丽君,陈聪语,肖云翔,黄燕波,杨洋,车新艳. 术前盆底肌电生理参数对前列腺癌根治性切除术后早期尿失禁的预测价值[J]. 北京大学学报(医学版), 2024, 56(4): 594-599.
[5] 刘圣杰,侯惠民,吕政通,丁鑫,王璐,张磊,刘明. 双极雄激素序贯免疫检查点抑制剂治疗转移性去势抵抗性前列腺癌4例[J]. 北京大学学报(医学版), 2022, 54(4): 766-769.
[6] 白杲琛,宋毅,金杰,虞巍,何志嵩. 多西他赛联合卡铂治疗转移性去势抵抗性前列腺癌的临床疗效[J]. 北京大学学报(医学版), 2021, 53(4): 686-691.
[7] 赵凯,常志芳,王志华,庞春艳,王永福. 基因沉默肽基精氨酸脱亚胺酶4的表达对胶原诱导关节炎小鼠肺间质病变的影响[J]. 北京大学学报(医学版), 2021, 53(2): 235-239.
[8] 徐涛,韩敬丽,姚伟娟. 雄激素剥夺治疗相关心血管疾病的机制与临床对策[J]. 北京大学学报(医学版), 2020, 52(4): 607-609.
[9] 孙奎霞,闫存玲,李志艳,刘平,张伟,何群. 前列腺特异性抗原同源异构体2及其衍生指标在预测前列腺癌病理分级中的价值[J]. 北京大学学报(医学版), 2020, 52(2): 234-239.
[10] 李文卿,任思楣,龙星博,田雨青. 棕榈酰化蛋白质组学分析揭示前列腺癌细胞中雄激素促进代谢相关蛋白棕榈酰化修饰[J]. 北京大学学报(医学版), 2020, 52(2): 227-233.
[11] 张宽根,周雨禾,邵雅昆,梅放,由江峰,刘北英,裴斐. 肿瘤转移抑制基因LASS2/TMSG1 S248A突变体通过增加ATP6V0C表达促进前列腺癌的侵袭[J]. 北京大学学报(医学版), 2019, 51(2): 210-220.
[12] 唐旭,赵卫红,宋琴琴,殷华奇,杜依青,盛正祚,王强,张晓威,李清,刘士军,徐涛. SOX10对前列腺癌细胞增殖及侵袭的影响[J]. 北京大学学报(医学版), 2018, 50(4): 602-606.
[13] 纪光杰,黄聪,宋刚,李学松,宋毅,周利群. 去势抵抗性前列腺癌进展时间的预测因素分析[J]. 北京大学学报(医学版), 2017, 49(4): 657-662.
[14] 闫新星,张巍,王晶,克晓燕. 沉默B7-H3基因抑制人恶性血液病裸鼠移植瘤的体内成瘤和转移[J]. 北京大学学报(医学版), 2017, 49(2): 286-294.
[15] 杨恺惟, 虞巍, 宋毅, 黄立华, 韩文科, 何志嵩, 金杰, 周利群. 影响多西他赛联合泼尼松治疗转移性去势抵抗性前列腺癌疗效的因素分析[J]. 北京大学学报(医学版), 2015, 47(4): 592-596.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!